U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H19N.ClH
Molecular Weight 297.822
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Norcyclobenzaprine hydrochloride

SMILES

Cl.CNCCC=C1C2=C(C=CC=C2)C=CC3=C1C=CC=C3

InChI

InChIKey=UZMPCPFDZYTEJG-UHFFFAOYSA-N
InChI=1S/C19H19N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-13,20H,6,14H2,1H3;1H

HIDE SMILES / InChI
Molecular Formula C19H19N
Molecular Weight 261.3609
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Norcyclobenzaprine (aka desmethylcyclobenzaprine) is one of the major metabolites of cyclobenzaprine which is a muscle relaxant marketed under the brand name Flexeril. Both cyclobenzaprine and norcyclobenzaprine are known to be potent antagonists of the serotonin 2a receptor.

CNS Activity

Originator

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
5-hydroxytryptamine receptor 2A
73
Target ID: P28223
Gene ID: 3356.0
Gene Symbol: HTR2A
Target Organism: Homo sapiens (Human)
Antagonist
2849
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
High-performance liquid chromatography-mass spectrometry for the quantification of nortriptyline and 10-hydroxynortriptyline in plasma.
1998-09-25
Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
1996-07
Potential interference of cyclobenzaprine and norcyclobenzaprine with HPLC measurement of amitriptyline and nortriptyline: resolution by GC-MS analysis.
1995-07-01
Metabolism of cyclobenzaprine in the dog.
1978-03-01
Patents

Patents

WO2009148623A2
2

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:45:19 GMT 2025
Edited
by admin
on Mon Mar 31 23:45:19 GMT 2025
Record UNII
VKZ2UCW7RG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Norcyclobenzaprine hydrochloride
Common Name English
Cyclobenzaprine related compound B [USP IMPURITY]
Preferred Name English
Norproheptatriene hydrochloride
Common Name English
10,11-Didehydronortriptyline hydrochloride
Common Name English
1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
Systematic Name English
1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride (1:1)
Systematic Name English
5H-Dibenzo[a,d]cycloheptene-?<SUP>5,?</SUP>-propylamine, N-methyl-, hydrochloride
Systematic Name English
Desmethyl cyclobenzaprine hydrochloride
Common Name English
Ro 4-6011
Code English
3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride
Systematic Name English
Code System Code Type Description
PUBCHEM
9917
Created by admin on Mon Mar 31 23:45:19 GMT 2025 , Edited by admin on Mon Mar 31 23:45:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID70963118
Created by admin on Mon Mar 31 23:45:19 GMT 2025 , Edited by admin on Mon Mar 31 23:45:19 GMT 2025
PRIMARY
FDA UNII
VKZ2UCW7RG
Created by admin on Mon Mar 31 23:45:19 GMT 2025 , Edited by admin on Mon Mar 31 23:45:19 GMT 2025
PRIMARY
CAS
438-59-5
Created by admin on Mon Mar 31 23:45:19 GMT 2025 , Edited by admin on Mon Mar 31 23:45:19 GMT 2025
PRIMARY
Related Record Type Details
Structure of NORCYCLOBENZAPRINE
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966